NYSE: IGC - IGC Pharma, Inc.

Yield per half year: -27.46%
Dividend yield: 0.00%
Sector: Healthcare

Share chart IGC Pharma, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About IGC Pharma, Inc.

IGC Pharma, Inc., a clinical stage biotechnology company, engages in developing cannabinoid-based formulations for treating diseases and conditions, including Alzheimer's disease, dysmenorrhea, premenstrual syndrome, and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease comprising IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63 that is in pre-clinical development.

more details
It also markets Holief, a wellness brand that targets women experiencing premenstrual syndrome and menstrual cramps. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2006-04-13
ISIN US45408X3089
Industry Trading Companies & Distributors
Sector Industrials
Валюта usd
Валюта отчета usd
Сайт https://igcpharma.com
Цена ао 0.31
Change price per day: 0% (0.2906)
Change price per week: +3.79% (0.28)
Change price per month: -9.19% (0.32)
Change price per 3 month: -12.73% (0.333)
Change price per half year: -27.46% (0.4006)
Change price per year: -50.45% (0.5865)
Change price per 3 year: -65.4% (0.84)
Change price per 5 year: -9.19% (0.32)
Change price per year to date: -21.35% (0.3695)
All parameters

Underestimation

Title Value Grade
P/S 17.5 1
P/BV 3.21 5
P/E 0 0
EV/EBITDA -2.48 0
Total: 4.13

Efficiency

Title Value Grade
ROA, % -96.01 0
ROE, % -116.95 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0377 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % -67.2 0
Yield Ebitda, % 55.27 7
Yield EPS, % 2.05 1
Total: 3
More

Institutions Volume Share, %
Blackrock Inc. 717884 1.81
Vanguard Group Inc 645166 1.63
Geode Capital Management, LLC 324296 0.82
State Street Corporation 184107 0.47
Dearborn Partners, L.L.C. 116710 0.29
Susquehanna International Group, LLP 76872 0.19
Northern Trust Corporation 71364 0.18
Bridgeway Capital Management, Inc. 69000 0.17
Goldman Sachs Group Inc 65495 0.17
Virtu Financial LLC 60723 0.15



Head Job title Payment Year of birth
Mr. Ram Mukunda President, CEO & Director 705k 1959 (66 years)
Ms. Claudia Grimaldi VP, Principal Financial Officer, Chief Compliance Officer & Non-Independent Director 245k 1972 (53 years)
Mr. Rohit Goel Senior Director of Accounting & Principal Accounting Officer N/A 1994 (31 year)
Benysh Qureshi Esq., M.B.A. Director of Operations

Address: United States, Potomac. MD, 10224 Falls Road - open in Google maps, open in Yandex maps
Website: https://igcpharma.com